Free Alerts   Login
Health Care › Surgical And Medical Instruments And Apparatus

TNDM Stock Price Correlated With Tandem Diabetes Care Financials

TNDM Stock Price vs. Quarterly
TNDM
Income Statement
Cash Flow
Balance Sheet

TNDM Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

TNDM Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

TNDM Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock.
9,245,653 sh
389,166 sh
4%
$273,487
$89,538
Vanguard Group
7,021,906 sh
18,571 sh
0%
$207,709
$62,250
Capital World Investors
6,384,111 sh
-161,227 sh
-2%
$188,842
$52,895
Eminence Capital, Lp
5,170,451 sh
-319,566 sh
-6%
$152,942
$38,914
FMR
2,977,274 sh
-14,793 sh
0%
$88,069
$25,925
Arrowmark Colorado Holdings
2,935,003 sh
1,303,459 sh
80%
$86,817
$52,930
Janus Henderson Group Plc
2,577,742 sh
-93,489 sh
-3%
$76,250
$20,769
State Street
2,274,566 sh
104,722 sh
5%
$67,282
$22,214
Bellevue Group Ag
1,992,317 sh
-100,617 sh
-5%
$58,933
$7,573
Champlain Investment Partners
1,529,832 sh
-86,047 sh
-5%
$45,252
$11,690
Jacobs Levy Equity Management
1,290,967 sh
497,479 sh
63%
$38,187
$21,706
Jennison Associates
1,290,590 sh
167,675 sh
15%
$38,175
$14,852
GW&K Investment Management
1,226,758 sh
1,226,758 sh
NEW
$36
$36
Capital International Investors
1,083,561 sh
-710,626 sh
-40%
$32,052
-$5,213
Paradice Investment Management
1,081,886 sh
-438,179 sh
-29%
$32,002
$430
Geode Capital Management
1,039,687 sh
40,376 sh
4%
$30,759
$10,000
Two Sigma Advisers, Lp
1,001,583 sh
-28,800 sh
-3%
$29,627
$8,226
Point72 Asset Management, L.P.
990,336 sh
990,336 sh
NEW
$29,294
$29,294
Stephens Investment Management Group
962,272 sh
-26,823 sh
-3%
$28,464
$7,920
Voloridge Investment Management
952,562 sh
-95,401 sh
-9%
$28,177
$6,411
COMPANY PROFILE
Organization and Basis of Presentation The Company

Tandem Diabetes Care, Inc. is a medical device company focused on the design, development and commercialization of technology solutions for people living with diabetes. Tandem Diabetes Care, Inc. is incorporated in the state of Delaware. Unless the context requires otherwise, the terms the “Company” or “Tandem” refer to Tandem Diabetes Care, Inc., together with its wholly-owned subsidiaries in the U.S. and Canada.

The Company manufactures, sells and supports insulin pump products that are designed to address the evolving needs and preferences of differentiated segments of the insulin-dependent diabetes market. The Company’s manufacturing, sales and support activities principally focus on the t:slim X2 Insulin Delivery System (t:slim X2), the Company’s flagship pump platform which is capable of remote software updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. The Company’s insulin pump products are compatible with other complementary digital health offerings, such as the t:connect cloud-based diabetes management application (t:connect) and the Tandem Device Updater, a Mac and PC-compatible tool which offers and supports updates of the Company’s insulin pump software from a personal computer. The Company’s insulin pump products are generally considered durable medical equipment and have an expected lifespan of at least four years. In addition to insulin pumps, the Company sells disposable products that are used together with the pumps and are replaced every few days, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to a user’s body, as well as other accessories for enhanced usability.

Basis of Presentation and Principles of Consolidation

The Company has prepared the accompanying consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. The statements include the accounts of Tandem Diabetes Care, Inc. and its wholly-owned subsidiaries in the U.S. and Canada. All significant intercompany balances and transactions have been eliminated in consolidation.

The functional currency of the Company’s foreign subsidiary is the local currency. The Company translates the financial statements of its foreign subsidiary into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. Translation related adjustments are included in other comprehensive income (loss), and in accumulated other comprehensive income (loss) in the stockholders’ equity section of the Company’s consolidated balance sheets. Foreign exchange gains or losses resulting from balances denominated in a currency other than the functional currency are recognized in interest income and other, net in the Company’s consolidated statements of operations.

Free historical financial statements for Tandem Diabetes Care Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 40 quarters since 2014. Compare with TNDM stock chart to see long term trends.

Data imported from Tandem Diabetes Care Inc SEC filings. Check original filings before making any investment decision.